FDA Inspection
Boehringer Ingelheim Roxane IncBoehringer Ingelheim Roxane Inc – FDA Inspection, Dec 3, 2010
Record Details
This FDA Inspection record concerns Boehringer Ingelheim Roxane Inc, with an inspection on December 3, 2010, issued by the Center for Drug Evaluation and Research, covering drugs.
- Inspection Date
- December 3, 2010
- Product Type
- Drugs
View Company Profile
ID · b2d485e6-c969-48cc-bd4f-62d28dcfd272
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 701082
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
FDA Citations
2- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
- 21 CFR 211.192Investigations of discrepancies, failures
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Boehringer Ingelheim Roxane Inc
1| Date | Classification | Office | Project area |
|---|---|---|---|
| December 23, 2009 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Boehringer Ingelheim Roxane Inc
- FDA Inspection 635825 - 2009-12-23
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.